Description Recombinant SARS-CoV-2 Spike RBD Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg319-Phe541) of 2019-ncov Spike RBD (Accession #YP_009724390.1) fused with a 6xHis tag at the C-terminus.
Bio-Activity Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-COV-2 Spike RBD Protein at 2ug/mL (100 uL/well) can bind Recombinant Human ACE2 with a linear range of 0.12-9.06 ng/mL.
Purity > 95% by SDS-PAGE;> 95% by HPLC
Endotoxin < 0.1 EU/ug of the protein by LAL method.
Formulation Lyophilized from a 0.22 um filtered solution of PBS, pH 7.4, or Supplied as a 0.22 um filtered solution in PBS, pH 7.4.
Species SARS-COV-2
Calculated MW 25.9kDa
Expressed Host HEK293 cells
Tag 6xHis tag at the C-terminus Gene ID 43740568
Storage Store the lyophilized protein at -20°C to -80°C for long term. After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week. or This liquid product is stable at -70°C for up to 6 months from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at the recommended temperature. Reconstitution For lyophilized protein: Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.
Alternative Names S1-RBD protein; NCP-CoV RBD Protein; novel coronavirus RBD Protein; 2019-nCoV RBD Protein; S glycoprotein Subunit1 RBD Protein; SARS-CoV-2; 2019-nCoV